Literature DB >> 29523867

Dos and Don'ts in the Management of Cirrhosis: A View from the 21st Century.

Mary J Thomson1,1, Elliot B Tapper1,1,1, Anna S F Lok1,1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29523867      PMCID: PMC6098714          DOI: 10.1038/s41395-018-0028-5

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  16 in total

Review 1.  Nutritional and metabolic issues in cirrhosis and liver transplantation.

Authors:  E Cabré; M A Gassull
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2000-09       Impact factor: 4.294

2.  Barriers to alcoholism treatment: reasons for not seeking treatment in a general population sample.

Authors:  B F Grant
Journal:  J Stud Alcohol       Date:  1997-07

Review 3.  Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement Initiatives.

Authors:  Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-19       Impact factor: 11.382

4.  Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis.

Authors:  Elliot B Tapper; Yesenia Risech-Neyman; Neil Sengupta
Journal:  Clin Gastroenterol Hepatol       Date:  2015-03-26       Impact factor: 11.382

5.  Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

6.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

Review 7.  Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Sehrish Kamal; Muhammad Ali Khan; Ankur Seth; George Cholankeril; Deepansh Gupta; Utkarsh Singh; Faisal Kamal; Colin W Howden; Christopher Stave; Satheesh Nair; Sanjaya K Satapathy; Aijaz Ahmed
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

8.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

9.  Performance standards for therapeutic abdominal paracentesis.

Authors:  Catherine M Grabau; Sharon F Crago; Linda K Hoff; Julie A Simon; Cheryl A Melton; Beverly J Ott; Patrick S Kamath
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

10.  Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management.

Authors:  Zafrina Poonja; Amanda Brisebois; Sander Veldhuyzen van Zanten; Puneeta Tandon; Glenda Meeberg; Constantine J Karvellas
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-24       Impact factor: 11.382

View more
  6 in total

1.  Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Puneeta Tandon; Florence Wong; Patrick S Kamath; Scott W Biggins; Guadalupe Garcia-Tsao; Jennifer Lai; Michael B Fallon; Paul J Thuluvath; Hugo E Vargas; Benedict Maliakkal; Ram M Subramanian; Leroy R Thacker; K Rajender Reddy
Journal:  Aliment Pharmacol Ther       Date:  2019-04-29       Impact factor: 8.171

2.  Nutritional Assessment in Inpatients With Cirrhosis Can Be Improved After Training and Is Associated With Lower Readmissions.

Authors:  Bradley Reuter; Jawaid Shaw; Jennifer Hanson; Victoria Tate; Chathur Acharya; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2019-08-21       Impact factor: 5.799

3.  Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis.

Authors:  Jasmohan S Bajaj; Puneeta Tandon; Jacqueline G OʼLeary; Florence Wong; Scott W Biggins; Guadalupe Garcia-Tsao; Patrick S Kamath; Benedict Maliakkal; Michael B Fallon; Jennifer C Lai; Paul J Thuluvath; Hugo E Vargas; Ram M Subramanian; Leroy R Thacker; K Rajender Reddy
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

4.  Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.

Authors:  Arpan Patel; Steven Asch; Anna Liza Antonio; Fasiha Kanwal; Karl Lorenz; Deborah Riopelle; Anna Dickey; Jennifer Larkin; Martin Lee; Anne Walling
Journal:  Dig Dis Sci       Date:  2020-01-11       Impact factor: 3.199

5.  Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis.

Authors:  Yuan Wang; Qingyu Zhang
Journal:  Iran J Public Health       Date:  2018-12       Impact factor: 1.429

Review 6.  Multiparametric MR mapping in clinical decision-making for diffuse liver disease.

Authors:  Helena B Thomaides-Brears; Rita Lepe; Rajarshi Banerjee; Carlos Duncker
Journal:  Abdom Radiol (NY)       Date:  2020-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.